Almoosa Health Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,360	1,202	978.97	816.04	701.54	628.97
Revenue Growth (YoY)	19.02%	22.82%	19.97%	16.32%	11.54%	-
Cost of Revenue	915.58	834.02	674.5	587.73	486.9	408.79
Gross Profit	444.85	368.32	304.47	228.31	214.64	220.17
Selling, General & Admin	222.96	200.05	190.33	172.75	147.89	113.81
Other Operating Expenses	-16.88	-18.22	-13.82	-	-	-
Operating Expenses	209.89	186.23	180.44	172.75	147.89	113.81
Operating Income	234.97	182.09	124.03	55.56	66.75	106.36
Interest Expense	-32.23	-80.53	-22.59	-15.38	-3.82	-3.02
Earnings From Equity Investments	0.96	1.19	-	-	-	-
Other Non Operating Income (Expenses)	7.78	-	-	15.36	9.03	5.64
EBT Excluding Unusual Items	211.48	102.74	101.45	55.54	71.96	108.99
Gain (Loss) on Sale of Assets	0.11	0.11	0.33	0.03	-0.07	0
Asset Writedown	-	-	-	-0.01	-0.01	-0.55
Pretax Income	211.59	102.85	101.78	55.56	71.88	108.44
Income Tax Expense	3.02	8.43	3.63	4.54	9.46	3.67
Net Income	208.57	94.42	98.15	51.02	62.42	104.77
Net Income to Common	208.57	94.42	98.15	51.02	62.42	104.77
Net Income Growth	244.31%	-3.79%	92.38%	-18.27%	-40.42%	-
Shares Outstanding (Basic)	42	35	35	35	0	-
Shares Outstanding (Diluted)	42	35	35	35	0	-
Shares Change (YoY)	19.50%	-	-	34900.00%	-	-
EPS (Basic)	4.99	2.70	2.80	1.46	624.20	-
EPS (Diluted)	4.99	2.70	2.80	1.46	624.20	-
EPS Growth	188.13%	-3.79%	92.38%	-99.77%	-	-
Free Cash Flow	-321.11	-56.66	-343.12	-318.15	-120.76	-286.89
Free Cash Flow Per Share	-7.68	-1.62	-9.80	-9.09	-1207.55	-
Dividend Per Share	1.950	1.000	-	-	-	-
Gross Margin	32.70%	30.63%	31.10%	27.98%	30.59%	35.00%
Operating Margin	17.27%	15.14%	12.67%	6.81%	9.52%	16.91%
Profit Margin	15.33%	7.85%	10.03%	6.25%	8.90%	16.66%
Free Cash Flow Margin	-23.60%	-4.71%	-35.05%	-38.99%	-17.21%	-45.61%
EBITDA	316.22	257.04	182.72	105.45	88.99	129.3
EBITDA Margin	23.24%	21.38%	18.67%	12.92%	12.68%	20.56%
D&A For EBITDA	81.25	74.95	58.69	49.89	22.24	22.94
EBIT	234.97	182.09	124.03	55.56	66.75	106.36
EBIT Margin	17.27%	15.14%	12.67%	6.81%	9.52%	16.91%
Effective Tax Rate	1.43%	8.19%	3.57%	8.17%	13.16%	3.38%
Advertising Expenses	-	19.17	8.96	10.58	7.2	3.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.